Skip to main content
letter
. 2023 Jun 9;136(14):1744–1746. doi: 10.1097/CM9.0000000000002735

Figure 1.

Figure 1

The performance of R2-ISS risk stratification. (A,B) PFS and OS according to R2-ISS. (C) The redistribution of patients with MM from R-ISS to R2-ISS. (D) OS of patients with R-ISS II redistributed by R2-ISS. CI: Confidence interval; HR: Hazard ratio;MM: Multiple myeloma; OS: Overall survival; PFS: Progression-free survival; R2-ISS: Second Revision of the International Staging System; R-ISS: Revision of the International Staging System.